What is Organogenesis Holdings Inc.'s share buybacks?

Organogenesis Holdings Inc. (ORGO) reported share buybacks of $6.37M in Q4 2024.

What does share buybacks mean?

Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Organogenesis Holdings Inc. ORGO Share Buybacks

Share Buybacks at other companies

LeMaitre VascularLMAT

$460K-23.5%

AngioDynamicsANGO

$0—

Tactile Systems TechnologyTCMD

$1.07M-89.3%

ITG

Integer HoldingsITGR

$50M—

AbbottABT

$180M-35.7%

SolventumSOLV

——

Other financials

Income statement

See full

Revenue$37.2M-57.1%

Gross profit$63.0M-22.5%

Operating income-$68.9M-158%

Net income-$53.2M-182%

EPS (diluted)-$0.44-159%

Balance sheet

See full

Cash & equivalents$91.4M-16.9%

Total debt$39.4M+24.8%

Total equity$244.6M+0.7%

Total assets$520.0M+11.3%

Cash flow

See full

Operating cash flow$21.1M+206%

CapEx$3.1M-13.2%

Free cash flow$18.0M+176%

Valuation

See full

Market cap$312.68M-23.7%

Enterprise value$260.72M-21.3%

P/E115×—

P/S0.6×-0.3×

Profitability

See full

Gross margin75.9%+0.8pp

Operating margin0.5%—

Net margin0.5%+0.3pp

FCF margin6.9%—

Returns & leverage

See full

Return on equity1.1%+0.6pp

Debt / equity0.2×0.0×

Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Organogenesis Holdings Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s share buybacks?: Organogenesis Holdings Inc. (ORGO) reported share buybacks of $6.37M in Q4 2024.
What does share buybacks mean?: Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.